Navigation Links
Flat panel displays


Introduction
One of the fastest-growing segments of the semiconductor industry is concerned with a new generation of graphic displays for communications and high-definition television sets. For phosphors that might be used as the active medium in such displays, the critical characteristics are the lifetimes and wavelengths of their emissions.


Experiment and Results
Because the lifetimes and wavelengths of emissions were required, the SPEX FLUOROLOG-τ steady-state and lifetime spectrofluorometer was chosen for this investigation. To further complicate matters, the lifetime of the phosphor had to be obtained in a short period (three to five minutes) because of the rapidly changing character of the material. In addition, the phosphor and matrix were highly scattering, so stray-light rejection was crucial.

Figure 1 shows the emission spectrum of the final phosphor, confirming a useful visible emission dominated by the 550-nm peak.


In Figure 2 the results of the quick lifetime study (eight frequencies scanned in five minutes) indicate a three-component system, dominated by a very fast (109 s) decay. This fast emission assures that the phosphor will produce a high quantum yield within a timeframe compatible with refreshing the CRTs screen.


Conclusion
This particular investigation of phosphor emission characteristics was made possible by the excellent stray-light reflection, sensitivity, and wide lifetime range of the FLUOROLOG-t producing rapid and accurate characterization of the phosphor.


back to top
'"/>

Source:


Page: All 1

Related biology technology :

1. National stem-cell panel, including UW profs, urges close watch on research
2. Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters
3. Gates displays softwares future to UW-Madison students
4. Outpouring of tsunami relief displays power of the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Flat panel displays

Other Biology Technology:LS9 and Procter & Gamble Launch Sustainable Chemicals Partnership 2Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 2Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 3Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 2Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 3Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 4Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 5Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 6Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 7Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 8